Global Liposomes Drug Delivery Market Study 2016-2026, by Segment (Liposomal doxorubicin, Liposomal Amphoteracin B, … …), by Market (Fungal Infection Therapy, Cancer Therapy ( Tumor therapy), … …), by Company (Johnson & Johnson, Gilead Sciences, … …)

  • Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

    The global Liposomes Drug Delivery market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

    Liposomal doxorubicin

    Liposomal Amphoteracin B

    Liposomal Paclitaxel


    Demand Coverage (Market Size & Forecast, Consumer Distribution):

    Fungal Infection Therapy

    Cancer Therapy ( Tumor therapy)


    Company Coverage (Sales data, Main Products & Services etc.):

    Johnson & Johnson

    Gilead Sciences

    Luye Pharma

    Sun Pharmaceutical



    Sigma-Tau Group

    Teva Pharmaceutical




    Celsion Corporation

    Kingond Pharm

    Shanghai New Asia

    Spectrum Pharmaceuticals

    Major Region Market

    North America



    South America

    Middle East & Africa


  • Table of Content

    1 Industry Overview

    1.1 Liposomes Drug Delivery Industry

    1.1.1 Overview

    1.1.2 Products of Major Companies

    1.2 Market Segment

    1.2.1 Industry Chain

    1.2.2 Consumer Distribution

    1.3 Price & Cost Overview

    2 Liposomes Drug Delivery Market by Type

    2.1 By Type

    2.1.1 Liposomal doxorubicin

    2.1.2 Liposomal Amphoteracin B

    2.1.3 Liposomal Paclitaxel

    2.1.4 Others

    2.2 Market Size by Type

    2.3 Market Forecast by Type

    3 Global Market Demand

    3.1 Segment Overview

    3.1.1 Fungal Infection Therapy

    3.1.2 Cancer Therapy ( Tumor therapy)

    3.1.3 Others

    3.2 Market Size by Demand

    3.3 Market Forecast by Demand

    4 Major Region Market

    4.1 Global Market Overview

    4.1.1 Market Size & Growth

    4.1.2 Market Forecast

    4.2 Major Region

    4.2.1 Market Size & Growth

    4.2.2 Market Forecast

    5 Major Companies List

    5.1 Johnson & Johnson (Company Profile, Sales Data etc.)

    5.2 Gilead Sciences (Company Profile, Sales Data etc.)

    5.3 Luye Pharma (Company Profile, Sales Data etc.)

    5.4 Sun Pharmaceutical (Company Profile, Sales Data etc.)

    5.5 Pacira (Company Profile, Sales Data etc.)

    5.6 Fudan-Zhangjiang (Company Profile, Sales Data etc.)

    5.7 Sigma-Tau Group (Company Profile, Sales Data etc.)

    5.8 Teva Pharmaceutical (Company Profile, Sales Data etc.)

    5.9 CSPC (Company Profile, Sales Data etc.)

    5.10 Novartis (Company Profile, Sales Data etc.)

    5.11 Crucell (Company Profile, Sales Data etc.)

    5.12 Celsion Corporation (Company Profile, Sales Data etc.)

    5.13 Kingond Pharm (Company Profile, Sales Data etc.)

    5.14 Shanghai New Asia (Company Profile, Sales Data etc.)

    5.15 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)

    6 Conclusion


This is a single user license, allowing one specific user access to the product.

This is an enterprise license, allowing all employees within your organisation access to the product.

Need Assistance ?

Our Clients